Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II1 Apr 2018MP64-10 INFILTRATING CD4+ T CELLS ATTENUATED THE SENSITIVITY OF CHEMOTHERAPY IN PROSTATE CANCER VIA SECRETING CCL5 Peng Xiang, Shuai Hu, Song Jin, Yang Yang, JingDong Sheng, and Jie Jin Peng XiangPeng Xiang More articles by this author , Shuai HuShuai Hu More articles by this author , Song JinSong Jin More articles by this author , Yang YangYang Yang More articles by this author , JingDong ShengJingDong Sheng More articles by this author , and Jie JinJie Jin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2055AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Management of castration-resistant prostate cancer (CPRC) remains challenging because of the unavoidable emergence of acquired resistance to chemotherapy with docetaxel(Doc). The tumor immune micro-environment as well as their secreted cytokines and growth factors play a substantial role in tumor survival and development of resistance to chemotherapy. Our early study have proved that CD4(+)T cells in prostate tumor micro-environment contribute to prostate cancer(PCa) progression, however, their effects on PCa chemo-sensitivity remained unclear. METHODS CD4+T cell infiltration from post-chemotherapy paraffin embedded specimens was performed by IHC. CRPC cell lines--C4-2, CWR22RV1 and CD4(+) T cell lines--HH and Molt-3 were used in vitro co-culture system. After 48 hours co-culture, the PCa cell chemo-sensitivity were detected by CCK8, Tunel and Western-blot. Various cell cytokine was determined by Cytokine arrays and QPCR. RESULTS We found more CD4+T cell infiltration in tumor area (Figure 1A) than in adjacent normal prostate (Figure 1B) in clinical samples. After co-culture with the CD4+T cells, C4-2 and 22Rv1 cells become more resistant to Doc treatment in a dose-dependent manner ranging from 1 nM to 8 nM (Figure 2A). Tunel results indicated that CD4+T cells protect PCa cells from Doc-induced apoptosis (Figure 2C). Meanwhile, the level of cleaved PARP, another indicator for the apoptotic process were also decreased (Figure 2B). QPCR and Cytokine arrays indicates that after co-culture with PCa CD4+T cells could secrete a significantly higher CCL5 (Figure 3A). Moreover, CCL5 stimulation enhanced PCa resistance to docetaxel(Figure 3B). Anti-ccl5 neutralization antibody could reverse co-culture PCa resistance to docetaxel. CONCLUSIONS CD4+T cells significantly attenuated prostate cancer chemo-sensitivity in vitro. Additionally, CCL5 secreted by CD4+T cells plays a key factor in chemo-therapy resistance. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e853-e854 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Peng Xiang More articles by this author Shuai Hu More articles by this author Song Jin More articles by this author Yang Yang More articles by this author JingDong Sheng More articles by this author Jie Jin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Infiltrating Mast Cells Increase Prostate Cancer Chemotherapy and Radiotherapy Resistances Via Modulation of P38/p53/p21 and ATM Signals

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Infiltrating Mast Cells Enhance Prostate Cancer Invasion Via Altering LncRNA-HOTAIR/PRC2-androgen Receptor (AR)-MMP9 Signals and Increased Stem/progenitor Cell Population

Correction: Infiltrating Mast Cells Increase Prostate Cancer Chemotherapy and Radiotherapy Resistances Via Modulation of P38/p53/p21 and ATM Signals.

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling

Infiltrated Pre-Adipocytes Increase Prostate Cancer Metastasis Via Modulation of the Mir-301A/androgen Receptor (Ar)/tgf-Β1/smad/mmp9 Signals.

Infiltrating T Cells Promote Prostate Cancer Metastasis Via Modulation of FGF11→miRNA‐541→androgen Receptor (AR)→MMP9 Signaling

Anti-androgen Therapy Induces Transcriptomic Reprogramming in Metastatic Castration-Resistant Prostate Cancer in a Murine Model.

Recruited Mast Cells in the Tumor Microenvironment Enhance Bladder Cancer Metastasis Via Modulation of ERβ/CCL2/CCR2 EMT/MMP9 Signals

The Effect of Mast Cells on the Biological Characteristics of Prostate Cancer Cells

Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.

Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6/STAT3/Cyclin D1 signals.

MP64-10 INFILTRATING CD4+ T CELLS ATTENUATED THE SENSITIVITY OF CHEMOTHERAPY IN PROSTATE CANCER VIA SECRETING CCL5

Docetaxel Remodels Prostate Cancer Immune Microenvironment and Enhances Checkpoint Inhibitor-Based Immunotherapy.

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Wild-Type P53 Suppresses The Epithelial-Mesenchymal Transition And Sternness In Pc-3 Prostate Cancer Cells By Modulating Mir-145

Single cell RNA-Sequencing Reveals Mast Cells Enhance Mononuclear Phagocytes Infiltration in Bladder Cancer Microenvironment

A Crosstalk Between Castration-Resistant Prostate Cancer Cells, M2 Macrophages, and NK Cells: Role of the ATM-PI3K/AKT-PD-L1 Pathway.

Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment Via IL-17 Pathway in Murine Hepatocarcinoma Model.

Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers.

The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer